Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials?
S. Jones, K. Kay, E. M. Hodel, M. Gruenberg, A. Lerch, I. Felger, I. Hastings
This paper evaluates deep sequenced amplicons (AmpSeq) as a method for molecular correction in malaria drug trials, finding it improves drug failure rate detection compared to current methods.
bioRxiv · Mar 23, 2021Microbiology